OUP user menu

How Molecular Testing Can Help (and Hurt) in the Workup of Gliomas

Kenneth Clark MD, Zoya Voronovich, Craig Horbinski MD, PhD
DOI: http://dx.doi.org/10.1309/AJCPFO8IIDNBIJ8Y 275-288 First published online: 1 March 2013


Advances in genetics research have greatly expanded our ability to accurately diagnose gliomas and provide more useful prognostic information. Herein specific examples are used to show how highyield targets such as EGFR, 1p/19q, IDH1/2, MGMT, and BRAF can expand the power of the surgical neuropathologist. To avoid errors, however, the significance and controversies associated with each test must be thoroughly understood.

Key Words
  • Glioma
  • EGFR
  • 1p/19q
  • BRAF
  • IDH1/2
  • MGMT
View Full Text